What proportion of patients with bone and soft tissue tumors contracted coronavirus-19 and died from surgical procedures during the initial period of the COVID-19 pandemic? results from the multicenter British Orthopaedic Oncology Society Observational Study
<p><strong>Background:</strong> Delivering uninterrupted cancer treatment to patients with musculoskeletal tumors has been essential during the rapidly evolving coronavirus 2019 (COVID-19) pandemic, as delays in management can be detrimental. Currently, the risk of contracting COVI...
Váldodahkkit: | Rajasekaran, RB, Ashford, RU, Cosker, TDA, Stevenson, JD, Jeys, L, Pollock, R, Rankin, KS, Cool, P, Patton, JT, Whitwell, D, Gibbons, CLMH, Carr, A, British Orthopaedic Oncology Society Collaborative Group* |
---|---|
Materiálatiipa: | Journal article |
Giella: | English |
Almmustuhtton: |
Lippincott, Williams & Wilkins
2020
|
Geahča maid
-
Service delivery during the COVID-19 pandemic: experience from the Oxford Bone Tumour and Soft Tissue Sarcoma service
Dahkki: Rajasekaran, RB, et al.
Almmustuhtton: (2020) -
Will virtual multidisciplinary team meetings become the norm for musculoskeletal oncology care following the COVID-19 pandemic? Experience from a tertiary sarcoma centre.
Dahkki: Rajasekaran, R, et al.
Almmustuhtton: (2021) -
Reconstruction after resection of a proximal humeral tumour: what challenges remain?
Dahkki: Rajasekaran, RB, et al.
Almmustuhtton: (2022) -
Surgical management of primary bone sarcomas
Dahkki: Cosker, TDA, et al.
Almmustuhtton: (2021) -
Patient safety associated with the surgical treatment of bone and soft tissue tumours during the COVID-19 pandemic—results from an observational study at the Oxford Sarcoma Service
Dahkki: Rajasekaran, RB, et al.
Almmustuhtton: (2020)